Extreme reduction of contrast dose with intravascular ultrasound guide PCI for patients with chronic kidney disease

Extreme reduction of contrast dose with intravascular ultrasound guide PCI for patients with chronic kidney disease - MINICON 2

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008922

Enrollment

100

Registered

2012-09-14

Start date

2012-09-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease requiring coronary intervention in patients with chronic kidney disease

Interventions

Percutaneous coronary intervention (PCI)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: * coronary artery disease requiring PCI * elective case * chronic kidney disease with estimated glomerular filtration rate (eGFR) less than 30 or eGFR between 30 and 45 with proteinuria (urine protein / Cr > 0.015 or urine microalbumin / Cr >30)

Exclusion criteria

Exclusion criteria: * Maintenance dialysis is started before PCI * Insufficient renal protection with saline or bicarbonate transfusion * plan of schedule surgery * renal transplantation * no indication of PCI * Others

Design outcomes

Primary

Measure	Time frame
All cause mortality and maitenance dialysis induction rate at 1 year	—

Secondary

Measure	Time frame
Achievement rate of minicon PCI Rate of contrast induced nephropathy defined as increase of Cr >0.5 or 25%. Mortality rate at 1 year Induction rate of maintenance dialysis at 1 year * Stroke rate at 1 year * Myocardial infarction rate at 1 year * repeat PCI at 1 year * bypass surgery at 1 year * Major adverse cardiac events (cardiac death, myocardial infarction, PCI or CABG) * Major adverse cardiac and cereblar events (all cause mortality, myocardial infarction, stroke and all revascularization) * Major adverse cardiac, cereblar and renal events (all cause mortality, myocardial infarction, stroke and indcution of dialysis)	—

Measure

Time frame

*Achievement rate of minicon PCI *Rate of contrast induced nephropathy defined as increase of Cr >0.5 or 25%. *Mortality rate at 1 year *Induction rate of maintenance dialysis at 1 year * Stroke rate at 1 year * Myocardial infarction rate at 1 year * repeat PCI at 1 year * bypass surgery at 1 year * Major adverse cardiac events (cardiac death, myocardial infarction, PCI or CABG) * Major adverse cardiac and cereblar events (all cause mortality, myocardial infarction, stroke and all revascularization) * Major adverse cardiac, cereblar and renal events (all cause mortality, myocardial infarction, stroke and indcution of dialysis)

—

Countries

Japan

Contacts

Public ContactFumie Saito

Tokai University Department of Cardiology

f.saito@tokai-u.jp0463-93-1121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026